HORMONES, HORMONE SUBSTITUTES, AND HORMONE ANTAGONISTS

Clinical trials for HORMONES, HORMONE SUBSTITUTES, AND HORMONE ANTAGONISTS explained in plain language.

Never miss a new study

Get alerted when new HORMONES, HORMONE SUBSTITUTES, AND HORMONE ANTAGONISTS trials appear

Sign up with your email to follow new studies for HORMONES, HORMONE SUBSTITUTES, AND HORMONE ANTAGONISTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 2 Not yet finished but already full! 1

Could a targeted drug delay prostate cancer progression?

Disease control Ongoing

This phase 3 trial tests whether adding the targeted drug abemaciclib to standard hormone therapy (abiraterone plus prednisone) can delay cancer growth in men with high-risk prostate cancer that has spread to bones or organs. Participants receive either abemaciclib or a placebo a…

Matched conditions: HORMONES, HORMONE SUBSTITUTES, AND HORMONE ANTAGONISTS

Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated Jul 02, 2026 04:00 UTC

HORMONES, HORMONE SUBSTITUTES, AND HORMONE ANTAGONISTS

Get alerted when new HORMONES, HORMONE SUBSTITUTES, AND HORMONE ANTAGONISTS trials appear

Could a targeted drug delay prostate cancer progression?